Trial of Adjuvant Chemotherapy for Gastric Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2010

Conditions
Stomach Cancer
Interventions
DRUG

cisplatin, mitomycin-C, doxifluridine

"Mf: Mitomycin-C 20mg/m2 intravenously (3-6 weeks after surgery) Doxifluridine 460-600mg/m2/day per oral for 3 months (started 4 weeks after surgery)~iceMFP: Cisplatin 100mg with 1L of normal saline intraperitoneally for 2 hours during surgery Mitomycin-C 15mg/m2 intravenously (1 day after surgery) Doxifluridine 460-600mg/m2/day per oral(started at 4 weeks after surgery and administered a total of 12 months) Cisplatin 60mg/m2 intravenously monthly for 6 months (started at 4 weeks after surgery)"

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Ulsan University Hospital

OTHER

collaborator

Hallym University Medical Center

OTHER

lead

Asan Medical Center

OTHER